Search

Your search keyword '"Singerman, Lawrence J."' showing total 172 results

Search Constraints

Start Over You searched for: Author "Singerman, Lawrence J." Remove constraint Author: "Singerman, Lawrence J."
172 results on '"Singerman, Lawrence J."'

Search Results

1. Switching to brolucizumab: injection intervals and visual, anatomical and safety outcomes at 12 and 18 months in real-world eyes with neovascular age-related macular degeneration

2. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

3. Prediction for 2-Year Vision Outcomes Using Early Morphologic and Functional Responses in the Comparison of Age-related Macular Degeneration Treatments Trials

4. Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2 A Randomized Clinical Trial

5. Macula Society Collaborative Retrospective Study of Ocriplasmin for Symptomatic Vitreomacular Adhesion

7. Long-term tamoxifen citrate use and potential ocular toxicity

8. One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents.

9. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

13. Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration A Randomized Phase 2 Trial

14. Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration

15. The detection and quantification of retinopathy using digital angiograms

16. Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials - TAP Report No. 5

17. Outcomes and Practice Preferences After Endophthalmitis Following Anti-VEGF Intravitreal Injection

18. The eye in systemic disease 1: anterior structures

19. The eye in systemic disease 2: the retina

20. Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema

21. Macula Society Collaborative Retrospective Study of Ocriplasmin for Symptomatic Vitreomacular Adhesion

24. Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials

25. Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration

30. Reading the retina in primary care

31. Eye to eye with systemic disease

39. Neovascular AMD: Treatment Beyond Anti-VEGF.

41. Authors' reply

43. Evaluation of Grid Pattern Photocoagulation for Macular Edema in Central Vein Occlusion

45. Advancing Treatments for Diabetic Macular Edema.

46. Treating Neovascular Peripheral Retinal Diseases.

Catalog

Books, media, physical & digital resources